Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Update Il y a 5 ans
Reference: NCT00101985

Woman and Man

Extract

This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).


Inclusion criteria

  • irritable colon


Links